GO
Loading...

Stop Trading!

Monday, 4 Jun 2007 | 4:56 PM ET

Even though Wal-Mart shares are continuing to move higher, you can still get in now, Cramer said today on Stop Trading! But he isn’t a fan of the retailer's plan to spin off Sam’s Club. There’s no reason for Sam’s Club to IPO, he said, because it’s a “good adjunct” to the rest of Wal-Mart.

Stop Trading!
Mad Money host Jim Cramer discusses the day's stock picks with CNBC's Erin Burnett

Cramer also said Celgene was “a great buy here.” At the American Society of Clinical Oncology Conference in Chicago this weekend, Celgene made a “major statement” about its cancer drug, Revlimid, which “just got ignored.” The stock has been on a tear for the past year, but Cramer thinks Revlimid gives it even more room for upside.

And Cramer said a Bear Stearns analyst upgrade of Sirius is a “big call.” Even though the stock is down today, Cramer said it has the chance to hit the analyst's $4 price target. Cramer has been bearish on both Sirius and XM Satellite Radio for a while, saying he thinks the only chance either company has of surviving is if they get clearance to merge.


Questions? Comments? madmoney@cnbc.com

  Price   Change %Change
CELG
---
SIRI
---
WMT
---

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.